Shane Johnson Appointed Chief Commercial Officer at New View Surgical

New View Surgical Inc. has welcomed Shane Johnson to its executive team as chief commercial officer.

Johnson is now responsible for leading the company’s commercialization activities. 

“We are excited to welcome Shane to New View Surgical as we look forward to launching our novel VisionPort System into the U.S. market later this year,” said Bryce Klontz, CEO of New View Surgical. “Shane’s leadership and broad experience in launching new and innovative devices will be essential to the success of our initial market release of the VisionPort System later this year.”

Johnson has a strong track record of success in the minimally invasive medtech industry, having built commercial capabilities, leading sales, operations, and marketing teams and cultivating strong key opinion leader relationships across multiple product lines and point of care environments. Of his more than 25 years of medical device experience, he has served the last 18 in commercial executive leadership roles. Johnson joins New View Surgical from Aerin Medical, where he spent the last five years as vice president of Sales, creating the strategy and building the organization for the launch of two products within the ENT space. Prior to Aerin Medical, Johnson served as vice president of Sales at Vertiflex, where he was the first commercial hire resulting in a $465 million acquisition by Boston Scientific Corp.. Nearly half of his career was spent at Kyphon in progressive sales leadership roles, with his last role in the organization as a vice president of Sales helping drive to a successful IPO and ultimately a $3.9B acquisition by Medtronic plc.

“New View Surgical is taking the bold step to reimagine laparoscopic visualization and create exceptional clinical and economic value,” commented Johnson. “I joined New View Surgical because of the unique opportunity to redefine how minimally invasive surgery can be accomplished. It is rare to find a product that can provide increased value across multiple stakeholders including the patient, physician and site of service. The vision that CEO, Bryce Klontz and the Board has created, along with the enormous market opportunity, positions New View Surgical to drive a paradigm shift within the minimally invasive surgical space.”

The VisionPort System is a novel surgical imaging and access system that simplifies laparoscopic procedures by reducing the need for a separate camera port and camera holder and allows multiple simultaneous views of the operative field. In emerging markets, the VisionPort System will greatly reduce the capital-intensive equipment currently required to perform minimally invasive surgery, and thus, making state-of-the-art technology more accessible. The VisionPort System is intended to be used in a broad range of diagnostic and therapeutic procedures within the thoracic and abdominal cavities and is adaptable to a wide variety of surgical environments, representing a significant market opportunity.
 
New View Surgical Inc. develops and commercializes the VisionPort System, a surgical imaging and access system for minimally invasive surgery. VisionPort combines multiple imaging and access devices into one simple, easy-to-use device that is disposable and is expected to bring a variety of clinical and economic advantages to minimally invasive surgery operating rooms around the world.